VYNE THERAPEUTICS INC. (YARW) Return on equity 2017–2025
VYNE THERAPEUTICS INC. (YARW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-95.4%FY2025 · since FY2017: -42.4% → -95.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -95.4% | -18.9 pp |
| FY2024 | -76.5% | -44.4 pp |
| FY2023 | -32.1% | +42.3 pp |
| FY2022 | -74.4% | +76.4 pp |
| FY2021 | -150.8% | +530.9 pp |
| FY2020 | -681.6% | -140.1 pp |
| FY2019 | -541.6% | -461.1 pp |
| FY2018 | -80.5% | -38.1 pp |
| FY2017 | -42.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice